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Introduction
For many years, the possibility of a causal relationship
between lithiasis and carcinoma of the biliary tract has
been under debate. In the gallbladder and extrahepatic
bile tract, chronic inflammation has been accepted as a
factor participating in the multistep process leading to
cancer [10, 31]. It has also been associated with the
presence of gastric and intestinal metaplasia and with
pre-cancerous lesions [1–3, 5–7, 13, 15, 17]. By con-
trast, in intrahepatic bile duct carcinoma, the role of
stones and inflammation is still controversial because
hepatolithiasis is rare in Western countries, and more
than 80% of cholangiocarcinomas have no history of
predisposing factors [21]. 
The expression of cytokeratins 7 (CK7) and cytoker-
atin 20 (CK20) in the biliary system has been assessed in
a few studies, and the results are confusing [8, 26, 27].
Moll found that neoplasms usually repeat the same CK7
and CK20 expression pattern of the epithelia from which
they originate [19]. Recently, Faa reported that CK20 is
a “bile duct type” cytokeratin, and that its expression dif-
fers in experimental models of bile duct and oval cell
proliferation, suggesting the existence of different mech-
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anisms regulating proliferation and differentiation of bil-
iary epithelial cells [9]. Molecular studies of cholangio-
carcinogenesis in rat livers have shown that alterations
induced by furan treatment (intestinal metaplasia and
“type intestinal” of cholangiocarcinoma) are different
from hyperplastic bile ductular alterations induced by
common bile duct ligation [24]. Hence, different patho-
genetic conditions appear to be responsible for the oc-
currence of bile duct carcinomas, and the correlation be-
tween inflammatory (lithiasis) or proliferative stimuli
(ductular proliferation) and metaplastic alterations is still
unclear. 
In an attempt to clarify the relationship between
metaplastic phenomena and the chain of events leading
to bile duct cancer, we used immunohistochemical
methods for the investigation of the expression pattern
of CK7 and CK20 in the gallbladder and in the intra-
and extrahepatic bile ducts, aiming to correlate the ex-
pression pattern of cytokeratins with conditions which
usually precede the occurrence of bile duct neoplasia.
Since an ultrastructural, histochemical and immunohis-
tochemical similarity between the gallbladder and the
extrahepatic bile ducts both in normal and in neoplastic
conditions is commonly accepted by various investiga-
tors [26, 27], we pooled together gallbladder and extra-
hepatic bile duct malignancy as “Extrahepatic Bile Duct
Carcinoma” (EBDC), which is morphologically differ-
ent from “Intrahepatic Bile Duct Carcinoma” (IBDC),
whose features are still ambiguous [8, 26].
Materials and Methods
Specimens
Between March 1998 and December 2001, we selected
our cases by a systematic search through the pathology
reports of the Department of Pathology of the Universi-
ty of Palermo. 
We identified 48 specimens that were grouped as fol-
lows: 
A) Inflamed gallbladders and extrahepatic bile ducts:
10 surgical specimens of lithiasic and/or inflamed gall-
bladders and extrahepatic bile ducts; 
B) 15 percutaneous liver biopsy specimens obtained
from patients with chronic hepatitis C, with primary bil-
iary cirrhosis or primary sclerosing cholangitis; 
C) EBDCs: 13 surgically resected specimens, 10
from gallbladder and 3 from large bile ducts; 
D) IBDCs: 10 specimens, 5 obtained by surgical re-
section and 5 by percutaneous liver biopsy. Two of these
cases were associated with sclerosing cholangitis, and
one with intrahepatic bile duct stones.
Immunohistochemistry
Formalin-fixed, paraffin-embedded tissue sections were
stained by Hematoxylin-Eosin and Alcian blue-PAS.
Immunohistochemical studies were done using the
Avidin-Biotin-Complex (ABC) technique. The primary
monoclonal antibodies (mAbs) used were CK7 (clone
OV-TL12/30) and CK20 (clone Ks 20.8), both obtained
from DAKO (A/S, Glostrup, Denmark). 
Sections were cut and then deparaffinized in xylene
and rehydrated through alcohols. To improve immuno-
staining, samples were digested with 0.1% trypsin be-
fore incubation with CK7 mAb, and microwaved in 10
mM citrate buffer (pH 6.0) before incubation with CK20
mAb. After incubation with CK7 and CK20 mAbs for
25 minutes at room temperature, sections were incubat-
ed with the secondary antibody, which was followed by
ABC, as described in the manufacturer’s instructions of
Universal LSAB (Dako). Amino-Ethil-Carbazole (AEC)
was used as chromogen. The slides were then counter-
stained with hematoxylin and routinely mounted. As a
positive control for CK7, we used intrahepatic bile ducts
present in each section; for CK20, immunostaining was
carried out on a section of rectal adenocarcinoma. For
both mABs, hepatocytes served as a negative control.
Quality assessment 
Each section was analyzed by two independent ob-
servers. As previously shown by Moll [19], in non-in-
flamed, non-lithiasic bile system, there was a strong and
diffuse immunoreactivity against CK7 mAb, whereas
less than 1% of cells were reactive against CK20 mAb
(Fig. 1A–B). Therefore, immunostaining for CK7 and
CK20 was considered negative when less than 1% of
cells were positively stained in the whole section.
Results
Results are summarized in Table 1.
Group A: Inflamed gallbladders and extrahepatic bile
ducts showed focal or diffuse hyperplastic, metaplastic
and sometimes dysplastic phenomena. All of them were
CK7+/CK20+ (Fig. 1C–E).
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Fig. 1. A–B: Normal gallbladder strongly reactive for CK7 (A, · 100) and negative for CK20 (B, · 100). c
C–D: Inflamed gallbladder showed focal (C, · 100) or diffuse positivity for CK20 in metaplastic and hyperplastic areas (D · 250). 
E: Hyperplastic area showed positivity for CK20 ( · 250); F: Metaplastic and focally dysplastic area immunoreactive for CK20 ( · 250). 
G–H: CK20 expression alone in surgically resected EBDC (G, ·1 00) and CK7 alone in a percutaneous liver biopsy of IBDC (H,
· 100).
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Table 1. CK 7 and 20 expression in normal tissues, inflamed
intra and extrahepatic bile ducts, EBDCs and EBDCs. 
CK 7 CK20
Normal Tissues + –
Extrahepatic Bile Ducts + +/–*
Intrahepatic Bile Ducts + –
Extrahepatic Bile Duct Carcinomas + +
Intrahepatic Bile Duct Carcinomas + –**
* Focal staining pattern for CK20 in inflamed extrahepatic bile
ducts was evident in areas of metaplastic phenomena (intesti-
nal or foveolar). 
** Only one case was CK20 positive among IBDCs, the “hepato-
lithiasis associate case”.
Group B: Inflamed intrahepatic bile ducts of liver biop-
sies were always CK7+/CK20–. In these specimens,
metaplastic changes were never expressed. 
Group C: Gallbladder carcinomas and EBDCs were
mostly CK7+/CK20+. CK20 showed either a focal or a
diffuse staining pattern, which was also present in the
adjacent dysplastic and/or metaplastic mucosa (Fig.
1F–G). Two cases of this group were CK7–/CK20–.
Morphologically, these were mucinous carcinomas with
a signet ring cell component. Goblet cell metaplasia was
never present in the adjacent mucosa, but there were
many areas of diffuse pseudopyloric metaplasia, which
were negative for CK7 and CK20. 
Group D: IBDCs were CK7+/CK20– (Fig 1H). Only one
specimen showed focal positivity for CK20. This patient
had intrahepatic bile duct stones. 
In general, the expression of CK20 in the extrahepatic
bile system was always associated with goblet cell
and/or foveolar metaplastic alterations. The metaplastic
surface epithelium was positive for CK20 (Fig. 1D),
even if sometimes apparently non-metaplastic cells
were also CK20 positive (Fig. 1C). Intensity and spread
of the CK20 expression were independent from the
grade of differentiation of EBDCs. Conversely, IBDC
cases did not show CK20, even independently of the
grade of differentiation, except for the patient with intra-
hepatic bile duct stones.
Discussion
In our study, we showed that in inflamed gallbladder
and extrahepatic bile ducts of group A, CK7 is always
expressed as in normal tissues [19] whereas CK20 is
also expressed and related to the presence of hyperplas-
tic and metaplastic phenomena (goblet cell and/or pseu-
dopyloric surface metaplasia). In areas of gastric meta-
plasia, surface foveolar metaplastic epithelia often ex-
press both CK7 and CK20. By contrast, metaplastic
pseudopyloric glands are often negative for both, a find-
ing similar to that reported by Moll and Remakaers for
normal gastric epithelium [19, 25]. Small normal and
proliferating bile ducts of group B are always
CK7+/CK20– as usually described for ductular struc-
tures; metaplastic changes were never expressed. 
Extrahepatic bile duct carcinomas are CK7+/CK20+
and often associated with metaplastic phenomena and
expression of CK20 in the adjacent mucosa. We did not
confirm the data reported by Duval et al. that the majori-
ty of EBDCs are CK7+/CK20–, which is probably due to
the use of a different cut-off level for positivity to assess
CK20 immunostaining [8]. 
All intrahepatic bile duct carcinomas were
CK7+/CK20–. They never showed metaplastic changes
or CK20 expression, neither in neoplastic areas nor in
adjacent non neoplastic bile ducts, except for the case of
the patient with intrahepatic bile duct stones, which
showed focal positivity for CK20. 
Regarding these data, our results are in contrast to
those of Rullier [26], who reported that about 47% of
peripheral cholangiocarcinomas were positive for
CK20, and to the results of Shimonishi [27], who
showed scattered positivity for CK20 in moderately and
poorly differentiated IBDCs. We found that the large
majority of IBDCs did not express CK20, and that the
expression pattern of cytokeratins was independent
from the differentiation grade. In general, we agree with
Rullier, who demonstrated a variability of CK20 posi-
tivity according to the different location of tumors in the
biliary tract, with an increase in expression ranging from
low in IBDCs (called “peripheral carcinomas”) to high
in EBDCs (“non peripheral carcinomas”). We found
only one case of IBDCs in association with intrahepatic
bile duct stones (or hepatolithiasis), which was diffusely
positive for CK7 and focally positive for CK20. This cy-
tokeratin expression pattern was similar to that of
EBDCs. As hepatolithiasis is rare in Western countries,
we did not find any other case of intrahepatic bile duct
stones. Previous studies demonstrated that in livers with
hepatolithiasis, intrahepatic bile ducts have metaplastic
changes similar to the well-known metaplastic lesions in
the gallbladder [14]. These cases sometimes evolve in
cholangiocarcinoma [12, 22, 23, 29, 30]. We feel that
hepatolithiasis may be the underlying condition related
to the appearance of CK20 expression in IBDCs. 
Metaplastic phenomena suggest the pluripotentiality
of cells during the differentiation process and the liabili-
ty to determine malignant transformation [13]. In our
study, it was evident that CK20 was not only expressed
in intestinal metaplastic goblet cells epithelia, but also
appeared in hyperplastic or even in morphologically
normal epithelia, suggesting that cytokeratin expression
may precede morphologic alterations. Thus, CK20 ex-
pression in an inflamed bile system could be an “early
marker” of metaplasia. About 80% of our EBDCs are
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CK7+/CK20+; hence, they probably derive from goblet
cells and/or pseudopyloric surface metaplasia, which is
detected by CK20 mAb [19]. We found that two EBDCs
cases were negatively stained for both cytokeratins,
while in the adjacent mucosa, there was no goblet cells
metaplasia, but only pseudopyloric gland metaplasia.
Although the role of pseudopyloric metaplasia in the se-
quence metaplasiafi dysplasia fi carcinoma is still con-
troversial [28], we think that cancer can arise from
metaplastic pseudopyloric glands which are CK7–/CK20–,
like their normal counterpart in the stomach [19]. 
Rullier recently hypothesized that CK20 expression
in peripheral and non-peripheral cholangiocarcinomas
is determined by the embryology of the biliary tree
[26]. Instead, we suggest the hypothesis that these tu-
mors are embriologically similar, but their peculiar cy-
tokeratin pattern depends on a diverse pathogenetic se-
quence underscoring two mechanisms of carcinogene-
sis. Concerning non-peripheral cholangiocarcinomas,
under a chronic inflammatory stimulus, the most likely
sequence is metaplasia fi dysplasia fi cancer. The ap-
pearance of CK20 expression could be its hallmark.
Conversely, the expression pattern of our peripheral
cholangiocarcinomas was CK7+/CK20–, like that of
normal and proliferating non neoplastic intrahepatic
bile ducts. Therefore, under a chronic proliferative
stimulus, a different sequence bypassing the “metapla-
sia step” could be the starter of most Western peripheral
cholangiocarcinomas through the following sequence:
ductular proliferationfi dysplasia fi cancer. Our hy-
pothesis, based on the ability of biliary cells to express
both cytokeratins, is supported by experimental obser-
vations in a model of bile duct and oval cell prolifera-
tion [9] and by molecular studies of rat liver cholangio-
carcinogenesis [24]. 
In conclusion, our study shows that the expression of
CK7 and 20, under specific stimuli, can be different from
normal tissues and related to the appearance of metapla-
sia. We suggest that CK7 and 20 expression patterns can
be useful for identifying metaplastic alterations at the
onset of the biliary tumors, and thus have diagnostic use-
fulness. Assessments of larger series of Western and
Eastern patients will test the concept that “peripheral”
and “non-peripheral” cholangiocarcinomas are immuno-
logically different, not because of embriologic reasons,
but as a result of a different multistep pathogenesis.
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